Literature DB >> 17207522

Optimal duration of antibiotic therapy in vertebral osteomyelitis.

F Roblot1, J M Besnier, L Juhel, C Vidal, S Ragot, F Bastides, G Le Moal, C Godet, D Mulleman, I Azaïs, B Becq-Giraudon, P Choutet.   

Abstract

OBJECTIVES: To compare the risk of relapse of vertebral osteomyelitis (VO), according to the duration of antibiotic therapy (< or =6 weeks versus >6 weeks).
METHODS: We performed a 10-year retrospective study to assess the risk of VO relapse and to verify that this risk was not enhanced in patients who received 6 weeks of antibiotic therapy (Group 1) as compared with those who received a longer treatment (Group 2). VO was diagnosed based on clinical manifestations, magnetic resonance imaging and/or computed tomography findings, and isolation of a pyogenic organism in blood cultures and/or a discovertebral biopsy. Relapse was diagnosed based on isolation of the same organism in blood cultures and/or a discovertebral biopsy. Outcome was evaluated 6 months post-treatment and in December 2004.
RESULTS: Group 1 included 36 patients (mean age, 58 +/- 15 years) and Group 2 included 84 patients (mean age, 67 +/- 15 years) (P = 0.003). Clinical data and microorganisms were comparable in the 2 groups. In the first 6 months, 6 (5%) patients died (Group 1, n = 2; Group 2, n = 4), and 5 (4%) in Group 2 relapsed, 2 with recurrent VO and 3 with recurrent bacteremia. In 2004, 91 patients were evaluated (mean follow-up, 40.6 +/- 31 months): 77 (85%) were cured, 13 (14%) died (Group 1, n = 3; Group 2, n = 10), 1 had VO due to a different microorganism (Group 2), and no long-term relapses occurred.
CONCLUSION: Our results suggest that antibiotic therapy of VO could be safely shortened to 6 weeks without enhancing the risk of relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207522     DOI: 10.1016/j.semarthrit.2006.09.004

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  41 in total

1.  Localized mandibular infection affects remote in vivo bioreactor bone generation.

Authors:  Emma Watson; Brandon T Smith; Mollie M Smoak; Alexander M Tatara; Sarita R Shah; Hannah A Pearce; Katie J Hogan; Jonathan Shum; James C Melville; Issa A Hanna; Nagi Demian; Joseph C Wenke; George N Bennett; Jeroen J J P van den Beucken; John A Jansen; Mark E Wong; Antonios G Mikos
Journal:  Biomaterials       Date:  2020-06-23       Impact factor: 12.479

2.  Adolescent vertebral osteomyelitis mimicking a neoplasm.

Authors:  Charlie D Wilson; Joshua Lee; Ronak Desai; Russell A Ward
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-16

3.  [Vertebral osteomyelitis].

Authors:  N Jung; H Seifert; J Siewe; G Fätkenheuer
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

Review 4.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Spondylodiscitis in patients under haemodyalisis.

Authors:  Ana Maria Cervan; Juan de Dios Colmenero; Alfonso Del Arco; Francisco Villanueva; Enrique Guerado
Journal:  Int Orthop       Date:  2011-12-03       Impact factor: 3.075

6.  Pyogenic sacroiliitis: diagnosis, management and clinical outcome.

Authors:  Tomas Kucera; Jindra Brtkova; Pavel Sponer; Lenka Ryskova; Eduard Popper; Martin Frank; Marie Kucerova
Journal:  Skeletal Radiol       Date:  2014-09-19       Impact factor: 2.199

7.  Six weeks antibiotic therapy for all bone infections: results of a cohort study.

Authors:  R Farhad; P-M Roger; C Albert; C Pélligri; C Touati; P Dellamonica; C Trojani; P Boileau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-10       Impact factor: 3.267

8.  Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.

Authors:  Sang Hoon Yoon; Sang Ki Chung; Ki-Jeong Kim; Hyun-Jib Kim; Yong Jun Jin; Hong Bin Kim
Journal:  Eur Spine J       Date:  2009-11-24       Impact factor: 3.134

9.  Utility of MRI in the follow-up of pyogenic spinal infection in children.

Authors:  Qiuyan Wang; Paul Babyn; Helen Branson; Dat Tran; Jorge Davila; Edrise L Mueller
Journal:  Pediatr Radiol       Date:  2009-09-10

10.  Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003.

Authors:  L Grammatico; S Baron; E Rusch; B Lepage; N Surer; J C Desenclos; J M Besnier
Journal:  Epidemiol Infect       Date:  2007-06-14       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.